AU4414400A - Lactic acid bacteria with anxiolytic properties and uses thereof - Google Patents

Lactic acid bacteria with anxiolytic properties and uses thereof

Info

Publication number
AU4414400A
AU4414400A AU44144/00A AU4414400A AU4414400A AU 4414400 A AU4414400 A AU 4414400A AU 44144/00 A AU44144/00 A AU 44144/00A AU 4414400 A AU4414400 A AU 4414400A AU 4414400 A AU4414400 A AU 4414400A
Authority
AU
Australia
Prior art keywords
lactic acid
acid bacteria
anxiolytic properties
anxiolytic
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44144/00A
Other languages
English (en)
Inventor
Jean-Michel Antoine
Chantal Cayuela
Marie-Christine Degivry
Christian Latge
Eric Postaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Publication of AU4414400A publication Critical patent/AU4414400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU44144/00A 1999-05-06 2000-05-05 Lactic acid bacteria with anxiolytic properties and uses thereof Abandoned AU4414400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905760 1999-05-06
FR9905760A FR2793257B1 (fr) 1999-05-06 1999-05-06 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
PCT/FR2000/001238 WO2000067696A2 (fr) 1999-05-06 2000-05-05 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Publications (1)

Publication Number Publication Date
AU4414400A true AU4414400A (en) 2000-11-21

Family

ID=9545277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44144/00A Abandoned AU4414400A (en) 1999-05-06 2000-05-05 Lactic acid bacteria with anxiolytic properties and uses thereof

Country Status (13)

Country Link
US (1) US6541027B1 (https=)
EP (1) EP1175221B1 (https=)
JP (1) JP4688298B2 (https=)
AT (1) ATE362765T1 (https=)
AU (1) AU4414400A (https=)
CA (1) CA2373112C (https=)
DE (1) DE60034940T2 (https=)
DK (1) DK1175221T3 (https=)
ES (1) ES2287011T3 (https=)
FR (1) FR2793257B1 (https=)
MX (1) MXPA01011248A (https=)
PT (1) PT1175221E (https=)
WO (1) WO2000067696A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444203B2 (en) * 1999-12-20 2002-09-03 Compagnie Gervais Danone Administering bacteria to improve sleep
FR2811333B1 (fr) * 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
JP3648233B2 (ja) * 2003-04-08 2005-05-18 明治飼糧株式会社 飼料組成物
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
FR2895877B1 (fr) 2006-01-06 2012-06-22 Gervais Danone Sa Poudre de lait fermente ou yaourt a haute densite en ferments lactiques
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
US20130302322A1 (en) 2012-05-11 2013-11-14 Five Prime Therapeutics, Inc. Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
JP2016505239A (ja) * 2012-10-25 2016-02-25 コンパニ・ジェルベ・ダノン ヘリコバクター・ピロリ感染症の治療用のストレプトコッカス・サーモフィルス株
SG11201506640TA (en) * 2013-02-27 2015-09-29 Meiji Co Ltd Anti-stress agent
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
EP3212191B1 (en) * 2014-10-28 2022-10-05 Medlab IP Pty Ltd. Treatment for depression and depressive disorders
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
EP3928625A4 (en) * 2019-02-19 2022-10-19 Kabushiki Kaisha Yakult Honsha PROCESS FOR THE PRODUCTION OF LACTIC ACID BACTERIA AND/OR BACTERIA OF THE GENUS BIFIDOBACTERIUM
JP7536504B2 (ja) * 2019-05-31 2024-08-20 株式会社明治 抑うつ症状改善剤及びそれを含む組成物
EP4522060A1 (en) * 2022-05-25 2025-03-19 Boston Scientific Scimed Inc. Attachment mechanism for using an endoscope with a surgical robot

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
WO1997045530A1 (en) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Use of streptococcus faecium strains and composition containing the same
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤

Also Published As

Publication number Publication date
DE60034940D1 (de) 2007-07-05
FR2793257B1 (fr) 2001-07-27
MXPA01011248A (es) 2002-11-04
ATE362765T1 (de) 2007-06-15
JP4688298B2 (ja) 2011-05-25
CA2373112A1 (fr) 2000-11-16
WO2000067696A3 (fr) 2001-03-22
DE60034940T2 (de) 2008-01-24
FR2793257A1 (fr) 2000-11-10
CA2373112C (fr) 2012-08-07
DK1175221T3 (da) 2007-10-08
WO2000067696A2 (fr) 2000-11-16
EP1175221A2 (fr) 2002-01-30
ES2287011T3 (es) 2007-12-16
US6541027B1 (en) 2003-04-01
JP2002544146A (ja) 2002-12-24
PT1175221E (pt) 2007-09-04
EP1175221B1 (fr) 2007-05-23

Similar Documents

Publication Publication Date Title
AU4414400A (en) Lactic acid bacteria with anxiolytic properties and uses thereof
BG105830A (en) C-21 modified epothilones
AU5397699A (en) Pasteurized or ultra-pasteurized complete nutritional compositions and products
AU300150S (en) Container with product
AU2002366854A1 (en) Isolated phages and their use in food or pet food products
WO2003011226A3 (en) Products and drug delivery vehicles
CA96354S (en) Dispensing container
WO2004103311A3 (en) Antibiotic composition
AU2002230878A1 (en) Method and system for inhibiting pathogenic and spoilage activity in products and the products treated thereby
GB2369777B (en) Food products with antimicrobial lactic acid bacteria
ZA200110384B (en) Method for the production of an immunostimulant milk product and uses thereof.
AU1341899A (en) Method for preparing food products by fermenting soy milk with streptococcus thermophilus
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
ZA200208262B (en) Inhibition of biological degradation in Fischer-Tropsch products.
AU7390200A (en) Maca and antler for augmenting testosterone levels
WO2000039281A3 (en) Liquid starter cultures having improved storage stability and use thereof
AU2002312778A1 (en) Type iii bacterial strains for use in medicine
AU300151S (en) Container with product
ZA200203008B (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
GB9923858D0 (en) Antimicrobial compositions
WO2003039270A1 (fr) Aliments et boissons agissant contre l'obesite
WO2000071149A3 (en) Therapeutic uses of bpi protein products in humans with otitis media with effusion
WO2001064899A8 (de) Nukleotidsequenzen kodierend für proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veränderter mikroorganismus
WO2000003009A3 (de) Gene zur biosynthese von anticapsin und bacilysin, ihre isolierung und verwendung
WO2003102190A3 (en) Bacterial polypeptides involved in viability

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase